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Introduction
What is the main question? State your considerations leading to the formulation of this question.
Material and Methods
Prior approval of an Institutional Review Board (IRB) is required for all investigations involving human subjects and animals. Animal experimentation must be performed according to the Helsinki Declaration.
Study design: Provide a short survey of the tests or experiments. Include the independent variable(s) manipulated, the dependent variable(s) measured and all controls.
Methods: Describe methods and apparatus in detail. Provide references and brief description of methods already published. Identify drugs and chemicals, including generic name, dosage and administration. Describe the pre-study condition of patients or animals.
Analysis: Defi ne the variables. Use statistical analysis that is appropriate for the study. Describe statistical methods used for each analysis; provide references for tests that are not well known.
Results
A concise report of important results only. Use fi gures and tables for the presentation of data; summarize the most important observations in the text. Start and end dates of the study must be indicated (from ... to, preferably exact dates, but at least months and year[s]).
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Discussion
Summarize main results and make sure you can answer the question asked in the introduction, briefl y supporting the answer with the relevant results. Explain and defend the answer, comment on contradictory or unexpected results and discrepancies with previous fi ndings. Elaborate on new and important aspects of the study.
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